Skip to main content
Top
Published in: Acta Neurochirurgica 2/2012

01-02-2012 | Clinical Article

5-Aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study

Authors: Marcel A. Kamp, Philipp Grosser, Jörg Felsberg, Philipp J. Slotty, Hans-Jakob Steiger, Guido Reifenberger, Michael Sabel

Published in: Acta Neurochirurgica | Issue 2/2012

Login to get access

Abstract

Background

Microsurgical, circumferential stripping of intracerebral metastases often proves to be insufficient to prevent local tumor recurrence.

Objective

We were interested in the potential impact of 5-aminolevulinic acid (5-ALA)-induced-fluorescence (5-AIF) as a diagnostic tool for the resection of intracerebral metastases.

Methods

A retrospective analysis was performed for 52 patients who underwent 5-AIF-guided resection for intracerebral mass lesions that histologically corresponded to metastases from tumors outside the central nervous system. The presence of ALA fluorescence in the tumor was determined in each patient. In 42 patients, fluorescence of the resection cavity after tumor removal was additionally recorded. Data were correlated with neuropathological findings in tissue specimens.

Results

A total of 32 of the 52 metastases (62%) exhibited 5-AIF in tumor parts. All 5-AIF-positive metastases exhibited an inhomogeneous fluorescence pattern. 5-AIF was neither associated with the histological type nor with the site of origin of the metastases. Residual fluorescence of the resection cavity was detected after macroscopically complete white light resection in 24 patients with 5-AIF positive metastases. Residual tumor tissue was histologically confirmed in 6 of 18 patients with available tissue specimens from such 5-AIF positive areas (33%).

Conclusions

The majority of metastases (62%) were 5-AIF positive, suggesting a potential impact of 5-AIF for improved visualization of metastatic tumor tissue within the brain. However, residual 5-AIF after macroscopically complete resection of a metastasis needs to be interpreted with caution because of the limited specificity for detection of residual tumor tissue.
Literature
1.
go back to reference Baas P, Triesscheijn M, Burgers S, van Pel R, Stewart F, Aalders M (2006) Fluorescence detection of pleural malignancies using 5-aminolaevulinic acid. Chest 129(3):718–724PubMedCrossRef Baas P, Triesscheijn M, Burgers S, van Pel R, Stewart F, Aalders M (2006) Fluorescence detection of pleural malignancies using 5-aminolaevulinic acid. Chest 129(3):718–724PubMedCrossRef
2.
go back to reference Baumert BG, Rutten I, Dehing-Oberije C, Twijnstra A, Dirx MJ, Debougnoux-Huppertz RM, Lambin P, Kubat B (2006) A pathology-based substrate for target definition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 66(1):187–194PubMedCrossRef Baumert BG, Rutten I, Dehing-Oberije C, Twijnstra A, Dirx MJ, Debougnoux-Huppertz RM, Lambin P, Kubat B (2006) A pathology-based substrate for target definition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 66(1):187–194PubMedCrossRef
3.
4.
go back to reference Brahimi-Horn MC, Chiche J, Pouyssegur J (2007) Hypoxia signalling controls metabolic demand. Curr Opin Cell Biol 19(2):223–229PubMedCrossRef Brahimi-Horn MC, Chiche J, Pouyssegur J (2007) Hypoxia signalling controls metabolic demand. Curr Opin Cell Biol 19(2):223–229PubMedCrossRef
6.
go back to reference Felsberg J, Thon N, Eigenbrod S, Hentschel B, Sabel MC, Westphal M, Schackert G, Wilhelm, Kreth F, Pietsch T, Loeffler M, Weller M, Reifenberger G and Tonn JC (2011) Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6, and PMS2 in paired primary and recurrent glioblastomas. Int J Cancer Felsberg J, Thon N, Eigenbrod S, Hentschel B, Sabel MC, Westphal M, Schackert G, Wilhelm, Kreth F, Pietsch T, Loeffler M, Weller M, Reifenberger G and Tonn JC (2011) Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6, and PMS2 in paired primary and recurrent glioblastomas. Int J Cancer
7.
go back to reference Gamarra F, Lingk P, Marmarova A, Edelmann M, Hautmann H, Stepp H, Baumgartner R, Huber RM (2004) 5-Aminolevulinic acid-induced fluorescence in bronchial tumours: dependency on the patterns of tumour invasion. J Photochem Photobiol B 73(1–2):35–42PubMedCrossRef Gamarra F, Lingk P, Marmarova A, Edelmann M, Hautmann H, Stepp H, Baumgartner R, Huber RM (2004) 5-Aminolevulinic acid-induced fluorescence in bronchial tumours: dependency on the patterns of tumour invasion. J Photochem Photobiol B 73(1–2):35–42PubMedCrossRef
8.
go back to reference Grimbergen MC, van Swol CF, van Moorselaar RJ, Uff J, Mahadevan-Jansen A, Stone N (2009) Raman spectroscopy of bladder tissue in the presence of 5-aminolevulinic acid. J Photochem Photobiol B 95(3):170–176PubMedCrossRef Grimbergen MC, van Swol CF, van Moorselaar RJ, Uff J, Mahadevan-Jansen A, Stone N (2009) Raman spectroscopy of bladder tissue in the presence of 5-aminolevulinic acid. J Photochem Photobiol B 95(3):170–176PubMedCrossRef
9.
go back to reference Huber RM, Gamarra F, Hautmann H, Häußinger R, Wagner S, Castro M, Baumgartner R (1999) 5-Aminolaevulinic Acid (ALA) for the fluorescence detection of bronchial tumors. Diagn Ther Endosc 5:113–118PubMedCrossRef Huber RM, Gamarra F, Hautmann H, Häußinger R, Wagner S, Castro M, Baumgartner R (1999) 5-Aminolaevulinic Acid (ALA) for the fluorescence detection of bronchial tumors. Diagn Ther Endosc 5:113–118PubMedCrossRef
10.
go back to reference Jenkinson MD, Haylock B, Shenoy A, Husband D, Javadpour M (2011) Management of cerebral metastasis: Evidence-based approach for surgery, stereotactic radiosurgery and radiotherapy. Eur J Cancer 47(5):649–655PubMedCrossRef Jenkinson MD, Haylock B, Shenoy A, Husband D, Javadpour M (2011) Management of cerebral metastasis: Evidence-based approach for surgery, stereotactic radiosurgery and radiotherapy. Eur J Cancer 47(5):649–655PubMedCrossRef
11.
go back to reference Kemmner W, Wan K, Ruttinger S, Ebert B, Macdonald R, Klamm U, Moesta KT (2008) Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer. FASEB J 22(2):500–509PubMedCrossRef Kemmner W, Wan K, Ruttinger S, Ebert B, Macdonald R, Klamm U, Moesta KT (2008) Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer. FASEB J 22(2):500–509PubMedCrossRef
12.
go back to reference Krammer B, Plaetzer K (2008) ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci 7(3):283–289PubMedCrossRef Krammer B, Plaetzer K (2008) ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci 7(3):283–289PubMedCrossRef
13.
go back to reference Leonhard M (1999) New incoherent autofluorescence/fluorescence system for early detection of lung cancer. Diagn Ther Endosc 5:71–75PubMedCrossRef Leonhard M (1999) New incoherent autofluorescence/fluorescence system for early detection of lung cancer. Diagn Ther Endosc 5:71–75PubMedCrossRef
14.
go back to reference Liu YL, Ang SO, Weigent DA, Prchal JT, Bloomer JR (2004) Regulation of ferrochelatase gene expression by hypoxia. Life Sci 75(17):2035–2043PubMedCrossRef Liu YL, Ang SO, Weigent DA, Prchal JT, Bloomer JR (2004) Regulation of ferrochelatase gene expression by hypoxia. Life Sci 75(17):2035–2043PubMedCrossRef
15.
go back to reference Neves S, Mazal PR, Wanschitz J, Rudnay AC, Drlicek M, Czech T, Wustinger C, Budka H (2001) Pseudogliomatous growth pattern of anaplastic small cell carcinomas metastatic to the brain. Clin Neuropathol 20(1):38–42PubMed Neves S, Mazal PR, Wanschitz J, Rudnay AC, Drlicek M, Czech T, Wustinger C, Budka H (2001) Pseudogliomatous growth pattern of anaplastic small cell carcinomas metastatic to the brain. Clin Neuropathol 20(1):38–42PubMed
16.
go back to reference Pichlmeier U, Bink A, Schackert G, Stummer W (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10(6):1025–1034PubMedCrossRef Pichlmeier U, Bink A, Schackert G, Stummer W (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10(6):1025–1034PubMedCrossRef
17.
go back to reference Stummer W, Hassan A, Kempski O, Goetz C (1996) Photodynamic therapy within edematous brain tissue: considerations on sensitizer dose and time point of laser irradiation. J Photochem Photobiol B 36(2):179–181PubMedCrossRef Stummer W, Hassan A, Kempski O, Goetz C (1996) Photodynamic therapy within edematous brain tissue: considerations on sensitizer dose and time point of laser irradiation. J Photochem Photobiol B 36(2):179–181PubMedCrossRef
18.
go back to reference Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392–401PubMedCrossRef Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392–401PubMedCrossRef
19.
go back to reference Teng L, Nakada M, Zhao SG, Endo Y, Furuyama N, Nambu E, Pyko IV, Hayashi Y, Hamada JI (2011) Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy. Br J Cancer 104(5):798–807PubMedCrossRef Teng L, Nakada M, Zhao SG, Endo Y, Furuyama N, Nambu E, Pyko IV, Hayashi Y, Hamada JI (2011) Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy. Br J Cancer 104(5):798–807PubMedCrossRef
20.
go back to reference Utsuki S, Miyoshi N, Oka H, Miyajima Y, Shimizu S, Suzuki S, Fujii K (2007) Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study. Brain Tumor Pathol 24(2):53–55PubMedCrossRef Utsuki S, Miyoshi N, Oka H, Miyajima Y, Shimizu S, Suzuki S, Fujii K (2007) Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study. Brain Tumor Pathol 24(2):53–55PubMedCrossRef
21.
go back to reference Yoo H, Kim YZ, Nam BH, Shin SH, Yang HS, Lee JS, Zo JI, Lee SH (2009) Reduced local recurrence of a single brain metastasis through microscopic total resection. J Neurosurg 110(4):730–736PubMedCrossRef Yoo H, Kim YZ, Nam BH, Shin SH, Yang HS, Lee JS, Zo JI, Lee SH (2009) Reduced local recurrence of a single brain metastasis through microscopic total resection. J Neurosurg 110(4):730–736PubMedCrossRef
22.
go back to reference Zaak D, Sroka R, Khoder W, Adam C, Tritschler S, Karl A, Reich O, Knuechel R, Baumgartner R, Tilki D, Popken G, Hofstetter A, Stief CG (2008) Photodynamic diagnosis of prostate cancer using 5-aminolevulinic acid–first clinical experiences. Urology 72(2):345–348PubMedCrossRef Zaak D, Sroka R, Khoder W, Adam C, Tritschler S, Karl A, Reich O, Knuechel R, Baumgartner R, Tilki D, Popken G, Hofstetter A, Stief CG (2008) Photodynamic diagnosis of prostate cancer using 5-aminolevulinic acid–first clinical experiences. Urology 72(2):345–348PubMedCrossRef
Metadata
Title
5-Aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study
Authors
Marcel A. Kamp
Philipp Grosser
Jörg Felsberg
Philipp J. Slotty
Hans-Jakob Steiger
Guido Reifenberger
Michael Sabel
Publication date
01-02-2012
Publisher
Springer Vienna
Published in
Acta Neurochirurgica / Issue 2/2012
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-011-1200-5

Other articles of this Issue 2/2012

Acta Neurochirurgica 2/2012 Go to the issue